Herbs (Global Traditional) · Amazonian
Sarsaparilla (Smilax regelii) (Smilax regelii)
Moderate Evidencebotanical1 PubMed Study
Hermetica Superfood Encyclopedia
Sarsaparilla (Smilax regelii) contains saponins and plant sterols that may support skin health and inflammatory responses. Traditional use for skin conditions and joint discomfort lacks clinical validation.
Sarsaparilla (Smilax regelii) is derived from the dried root of a perennial trailing vine native to Central America. The root is traditionally processed by drying and boiling in water or alcohol to yield decoctions or tinctures containing steroidal saponins like parillin and phytosterols.
No human clinical trials, RCTs, or meta-analyses specific to Smilax regelii sarsaparilla were identified in the available research. While the herb appears in some FDA-labeled homeopathic products for conditions like cracked skin and bladder incontinence, these applications lack supporting clinical trial data.
No clinically studied dosage ranges are available for Smilax regelii extracts or standardized forms. Historical preparations mentioned include decoctions using 1 pound of root in 2 gallons of boiling water, but these lack modern standardization. Consult a healthcare provider before starting any new supplement.
Sarsaparilla root (Smilax regelii) is not consumed as a significant dietary macronutrient source. Macronutrient composition per 100g dried root is estimated at: carbohydrates 60-70g (primarily as starch and structural polysaccharides), fiber 15-20g (cellulose, hemicellulose), protein 5-8g, fat <2g. Caloric contribution is nutritionally negligible at typical supplemental doses (1-4g). Key bioactive compounds are steroidal saponins at 1-3% total concentration, dominated by sarsasaponin (parillin) and smilasaponin (sarsaparilloside), with smilagenin and sarsasapogenin as their respective aglycone forms. Phytosterols including beta-sitosterol and stigmasterol are present at approximately 0.1-0.5% dry weight. Polyphenolic content includes flavonoids (astilbin, engeletin) at roughly 0.2-0.8% and phenolic acids including ferulic and caffeic acid at trace levels. Mineral content includes modest potassium (~400-600mg/100g dried root), calcium (~150-250mg/100g), magnesium (~80-120mg/100g), and trace iron (~5-10mg/100g), though bioavailability from root preparations is low due to phytate and fiber binding. Starch granules contribute to bulk. The saponins are the most pharmacologically relevant fraction; they exhibit surfactant properties that are theorized to form complexes with gut-lumen endotoxins and to enhance intestinal permeability of co-administered phytochemicals, supported by preliminary in vitro binding studies rather than clinical pharmacokinetic data. No significant vitamin content has been documented.
Sarsaparilla's saponins, particularly sarsasapogenin and smilagenin, may modulate inflammatory pathways by inhibiting nuclear factor-kappa B (NF-κB) activation. The plant sterols could influence prostaglandin synthesis and cytokine production. These compounds may also affect hepatic detoxification enzymes, though specific mechanisms remain poorly characterized.
No randomized controlled trials exist for Sarsaparilla's health effects in humans. Traditional use studies from the 19th century documented dermatological applications but lacked standardized methodology. One small in vitro study suggested anti-inflammatory activity of isolated saponins, but human bioavailability data is absent. Current evidence consists entirely of traditional use reports and preliminary laboratory research.
Sarsaparilla appears generally well-tolerated in traditional dosages, though gastrointestinal upset may occur with high doses. Potential interactions with lithium exist due to possible diuretic effects. Safety during pregnancy and breastfeeding is unknown due to lack of studies. Large amounts may theoretically interfere with digoxin absorption due to saponin content.
